Lecture 11 cGMP

  • Upload
    pankmbm

  • View
    245

  • Download
    0

Embed Size (px)

Citation preview

  • 7/31/2019 Lecture 11 cGMP

    1/26

    cGMPEleven Lecture

  • 7/31/2019 Lecture 11 cGMP

    2/26

    Intermediate and Bulk Products

    1. Intermediate and bulk products should be kept underappropriate conditions

    2. Intermediate and bulk products purchased as such should behandled as were starting materials .

    Finished Products

    1. Finished products should be held in quarantine until their final

    release .2. The evaluation of finished products and documentation

    necessary for release of a product for sale .

  • 7/31/2019 Lecture 11 cGMP

    3/26

    Rejected and Recovered Materials

    1. Rejected materials and products should be clearly marked as

    such and stored separately in restricted areas . They should

    either returned to the suppliers or reprocessed or destroyed .

    2. The reprocessing of the rejected products is permitted only ifthe product quality is not affected i.e. if the product

    specification is met .

    Recalled Products

    Recalled products should be identified and stored separately ina secure area until a decision is taken on their fate .

  • 7/31/2019 Lecture 11 cGMP

    4/26

    Documentation

    The documents required are :1. Labels :Labels applied to containers, equipment or premises should be clear and in

    companysagreed format . It is helpful in addition to wording on the labels to use colors to

    indicatestatus ( quarantined, accepted, rejected, or clean ) .The label for finished product should bearing the following information :a. The name of the drug productb. A list of active ingredients .c. The batch number assigned by the manufacturer .

    d. The expiry date in an uncooked form .e. Any special storage conditions or handling precautions that necessaryf. Directions for use, and warnings and precautions that necessary .g. The name and address of the manufacturer or company .

  • 7/31/2019 Lecture 11 cGMP

    5/26

    Specifications and Testing Procedures

    1. Testing procedures described in documents should be validated

    before they are adopted for testing .

    2. There should be appropriately authorized and dated

    specifications including : tests on identity , content uniformity ,

    purity and quality for staring and packaging materials andfinished products . Also specification for water , solvent , and

    reagents used in production .

    3. Each specification should be approved and maintained by the

    quality control unit .4. Periodic revisions of the specifications may be necessary to

    comply with new editions of Pharmacopoeia .

  • 7/31/2019 Lecture 11 cGMP

    6/26

    Specifications for Starting and Packaging materials

    Specifications for starting and primary or printedpackaging materials should provide, a description of thematerials including :

    a. The designated name and internal code reference .

    b. The reference to a pharmacopoeia monograph .c. Qualitative and quantitative requirements with acceptance

    limits .d. The supplier and the original producer of the materialse. Directions for sampling and testing .

    f. A specimen of the printed materials .g. Storage conditions and precautions .j. The maximum period of storage before re-examination

  • 7/31/2019 Lecture 11 cGMP

    7/26

    Specifications For Finished Products

    Specifications for finished products should include :

    1. The designated name of the product and the code reference

    where applicable .

    2. The designated name of the active ingredients .

    3. The formula or a reference to the formula .

    4. A description of the dosage form and package details .

    5. Directions of sampling and testing or a reference to procedure .

    6. The qualitative and quantitative requirements with acceptancelimits .

    7. The storage conditions and precautions .

    8. The shelf-life .

  • 7/31/2019 Lecture 11 cGMP

    8/26

    Master Formulae

    A formally authorized master formula should exist for

    each product and batch size to be manufactured .

    The master formula should include :

    1. The name of the product .2. A description of the dosage form, strength and batch size

    3. A list of all starting materials to be used with the amount of each .

    4. A statement of the expected final yield with the acceptable limits .

    5. A statement of the processing location and the principleequipment to be used .

  • 7/31/2019 Lecture 11 cGMP

    9/26

    Master Formulae ( cont..)

    6. The methods or the reference to the methods to be used for

    preparing the critical equipment e.g. cleaning, assembling,

    calibrating and sterilization .

    7. Detailed stepwise processing instructions .

    8. The instructions for any in-process controls with their limits .

    9. The requirements for storage of the products, including the

    container, the labeling etc. .10. Any special precautions to be observed .

  • 7/31/2019 Lecture 11 cGMP

    10/26

    Packaging Instructions

    Formally authorized packaging instructions should existfor each product, pack size and type . These should

    include the following :

    1. The name of the product .

    2. A description of its pharmaceutical form, its strength and routeof administration .

    3. The pack size expressed in terms of the number, weight, orvolume of the product in the final container .

    4. A complete list of all packaging materials required for astandard batch size, including quantities, sizes, and types withthe code number relating to the specifications for eachpackaging materials .

  • 7/31/2019 Lecture 11 cGMP

    11/26

    Packaging Instructions ( cont.. )

    5. Example of the printed packaging materials indicating where

    the batch number and expiry date of the product have been

    marked .

    6. Special precautions to be observed including examination ofthe packaging area and equipment in order to ascertain the

    line clearance before operations begin .

    7. A description of the packaging operation and equipment to be

    used .8. Details of in-process controls with instructions for sampling and

    acceptance limits .

  • 7/31/2019 Lecture 11 cGMP

    12/26

    Batch Processing Records

    1. A batch processing record should be kept for each batchprocessed .

    2. Before any processing begins a check should be made that theequipment and work station are clear of previous products,documents, or materials not required for the process, and the

    equipment is clean and suitable for use . This check should berecorded .

    3. During the processing the following information should berecorded at the time each action is taken :

    i. The name of the product .

    Ii. The number of the batch being manufactured .Iii. Dates and times of the beginning of stages and completion of

    production .

  • 7/31/2019 Lecture 11 cGMP

    13/26

    Batch Processing Records ( cont.. )

    iv. The name of the person responsible for each stage ofproduction .

    v. The initials of the operator of different steps of production andof person who checked each of these operations .

    vi. The batch number / control number and the quantity of eachstarting material actually weighed .

    vii. Any relevant processing operation and the major equipmentused .

    viii. The in-process controls performed, and the results obtained .ix. The the yield of the product with explanations for deviations

    from the expected yield .

  • 7/31/2019 Lecture 11 cGMP

    14/26

    Batch Packaging Records

    It should be based on the relevant parts of the packaging

    instructions . It include the following information :

    1. Before any packaging operation begins, checks should be madethat the equipment and workstation are clear .

    2. The name of the product, the batch number, and the quantityof bulk product to be packed, as well as the quantity of thefinished product that will be obtained .

    3. The date and time of the packaging operations .

    4. The name of the responsible person carrying out the packagingoperation .

    5. The checks made for identity and conformity with thepackaging instructions including the in-process controls .

  • 7/31/2019 Lecture 11 cGMP

    15/26

    Batch Packaging Records ( cont.. )

    6. Details of the packaging operations carried out .

    7. Samples of the printed packaging materials used .

    8. Notes on any special problems including any deviation from

    packaging instructions .

    9. The quantities of all printed materials and bulk product issued,used, destroyed, or returned to the stock and the quantities of

    the product obtained to permit an adequate reconciliation .

  • 7/31/2019 Lecture 11 cGMP

    16/26

    Standard Operating Procedures ( SOPs)

    There should be standard operating procedures and

    records for the receipt of each delivery of starting

    material and primary and printed packaging material .

    The records for the receipts should include :

    1. The name of the material on the delivery note and the containers .

    2. The in house name / code number of material

    3. The date of the receipt

    4. The suppliers name and if possible the manufacturers name .5. The manufacturers batch or reference number

    6. The total quantity and the number of containers received .

    7. Any relevant comment e.g. state of the containers .

  • 7/31/2019 Lecture 11 cGMP

    17/26

    SOP for Sampling

    The sampling instructions should include :

    1. The method of sampling and the sampling plan .

    2. The equipment to be used .

    3. Any precautions to be observed to avoid contamination of the

    material or any deterioration in its quality .

    4. The amounts of sample to be taken .

    5. Instructions for any required subdivision of the sample

    6. The type of sample containers to be used .7. Any specific precautions to be observed specially in regard to

    the sampling of sterile material .

  • 7/31/2019 Lecture 11 cGMP

    18/26

    Good Practices in Production and Quality Control

    1. All handling of materials and products should be done in

    accordance with written procedures or instructions .

    2. Any deviation from instructions should be avoided and if it

    occur they should be approved in writing by a designated

    person .

    3. Checks on yields and reconciliation of quantities should be

    carried out to ensure there are no discrepancies outside

    acceptable limits .

    4. Operations on different products should not be carried out

    simultaneously or consecutively in the same room unless is no

    risk of mix-up or cross-contamination .

  • 7/31/2019 Lecture 11 cGMP

    19/26

    Good Practices in Production and Quality Control

    ( cont.. )

    5. Access to production premises should be restricted to

    authorized personnel .

    6. At all the times during processing all materials, bulk containers,

    equipment, and rooms used should be labeled that the product

    or material being processed , its strength, the batch number

    and the stage of production .

    7. In-process controls are performed within the production area .

  • 7/31/2019 Lecture 11 cGMP

    20/26

    Prevention of Cross-Contamination and Bacterial

    Contamination in Production

    Cross-contamination can be avoided by technical or

    organizational measures , for example :

    1. Production in segregated areas or by campaign followed byappropriate cleaning .

    2. Providing appropriate airlocks, pressure differentials, airextraction .

    3. Wearing protective clothing in areas where products withspecial risk of cross-contamination are processed

    4. Using cleaning procedures of known effectiveness .

    5. Using closing system of production .6. Testing for residues .

    7. Using cleanliness status labels on equipment .

  • 7/31/2019 Lecture 11 cGMP

    21/26

    Good Practices in Quality Control

    Quality control is concerned with :Sampling , Specifications , Testing as well as with

    organization, documentation , and release procedures .

    Quality control is not confined to laboratory operations,

    but must be involved in all decisions that may concern

    the quality of the product .

    Quality control unit should perform the following :

    1. All test procedure for each material or product .

    2. Samples should be representative of the batches of material

    from which they are taken in accordance with the approved

    written procedure .

  • 7/31/2019 Lecture 11 cGMP

    22/26

    Good Practices in Quality Control ( cont.. )

    3. Sampling should be carried out so as to avoid contamination orother adverse effects on quality .

    4. Sampling equipment should be cleaned before and after each useand stored separately from other laboratory equipment .

    5. Each sample container should be a label indicating :a. The name of the sample material .

    b. The batch or lot number .

    c. The number of container from which the sample has

    been taken .d. The signature of the person who has taken the sample .

    e. The date of sampling .

  • 7/31/2019 Lecture 11 cGMP

    23/26

    Test Requirements

    Before releasing a staring or packaging material for use,the quality control manager should ensure that :

    1. The materials have been tested for conformity with

    specifications for identity , strength , purity and other

    quality parameters .

    2. An identity test should be conducted on a sample from each

    container of starting materials .

    3. Each batch of printed packaging materials must be examined

    following receipt .

    4. A certificate of analysis may be accepted from supplier,

    certificate must be originals, and the certificate must contain

    the following information :

  • 7/31/2019 Lecture 11 cGMP

    24/26

    Test Requirements ( cont.. )

    4. A certificate of analysis may be accepted from supplier,

    certificate must be originals, and the certificate must containthe following information :

    1. Identification of the issuing supplier, signature of the manager

    or director of QC lab .

    2. The name and the batch number of the material tested .

    3. A statement of specifications and methods used .

    4. A statement of test results obtained and the date of testing .

  • 7/31/2019 Lecture 11 cGMP

    25/26

    Stability Studies

    1. The QC unit should evaluate the quality and stability of finishedproducts and when necessary of starting materials andintermediate products .

    2. The QC unit should establish expiry dates and shelf-lifespecifications on the basis of stability tests related to storageconditions .

    3. A written programmed for ongoing stability determinationshould be developed and implemented to include :

  • 7/31/2019 Lecture 11 cGMP

    26/26

    Stability Studies ( cont.. )

    a. A complete description of the drug used in the study .

    b. A complete testing parameters and methods for potency, and

    physical characteristics .

    c. Provision for inclusion of sufficient number of batches

    d. The testing schedule for each drug .

    e. Provision for special storage conditions .

    f. Provision for adequate sample retention .g. A summary of all data generated, including evaluation and the

    conclusion of the study .